The National Institute of Neurological Disorders and Stroke (NINDS) encourages small business innovation research (SBIR) and small business technology transfer (STTR) applications for projects to develop and apply nanotechnology to biomedicine. This announcement is made together with 18 other components of the National Institutes of Health (NIH).*
Nanotechnology is the creation of functional materials, devices, and systems through control of matter at the scale of 1 to 100 nanometers, and the exploitation of novel properties and phenomena at the same scale. Nanotechnology is emerging as a field critical for enabling essential breakthroughs that may have tremendous potential for affecting biomedicine.
Areas of research interest include, but are not limited to: nanomaterials (enabling)—development of synthetic nanoscale building blocks for the formulation of bottom-up approaches to complex and multi-functional nanomaterials; nano-bio interfaces—science of controlling the interface between biomolecular systems and nanoscale synthetic materials, which involves the ability to control the interface architecture and transduction of the control signal through this interface; nanoimaging—real-time imaging of subcellular structure, function, properties, and metabolism; cell biology—nano-scale research on cellular processes, including biophysics of molecular assemblies, membranes, organelles, and macromolecules; molecular and cellular sensing/signaling—technologies to detect biological signals and single molecules within and outside cells; and prosthetics—mechanical, chemical, and cellular implant nano-technologies to achieve functional replacement tissue architectures and tissue-compatible devices.
*For a full list of supporting NIH components and a more detailed description of this announcement, please visit the NIH web site at: http://grants.nih.gov/grants/guide/pa-files/PA-06-009.html (SBIR) or http://grants.nih.gov/grants/guide/pa-files/PA-06-008.html (STTR).